Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CNS.

NCT06498726 is registered in ClinicalTrials.gov with Eman Abdul-Hai as lead sponsor.

NCT NCT06498726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06498726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CNS.
Lead sponsor
Eman Abdul-Hai
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2024
Completion date
October 1, 2025
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood disease, brain injuries